Women in England with incurable breast cancer to get life-extending drug on NHS
Thousands with HER2-low advanced breast cancer will have access to Enhertu after ministers strike deal on price
The Guardian - UK ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
The Latest Breaking News from Claire Rowney
Women dying of breast cancer as life-extending drug remains blocked in England
A campaign is calling for Enhertu to be made available on the NHS.
Evening Standard ·
Breast cancer could cost UK economy £4.2bn by 2050, report suggests
The figures include the costs to the NHS of diagnosing and treating the disease, as well as the cost to the economy in lost productivity.
Evening Standard ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Daily tablet for advanced breast cancer patients set for NHS rollout
Elacestrant is recommended for patients whose cancer has worsened after at least a year of treatment with hormone therapy and CDK4/6 inhibitor.
The Independent UK ·
Breast cancer drug blocked for NHS use in England and Wales after talks collapse
National Institute for Health and Care Excellence unable to reach price agreement with manufacturers of Enhertu
The Guardian - UK ·
Coverage From
The Independent UK
Evening Standard
The Guardian - UK
People
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Organisations
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Topics
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
